Why BiondVax Shares Are Soaring Today
BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV) is trading higher Wednesday after the company announced it signed definitive agreements for the development and commercialization of nanosized COVID-19 antibody therapies with Max Planck Society and the University Medical Center Göttingen.
